TCRT
Companies
NASDAQ
Alaunos Therapeutics Inc.
Health Care
$4.00
+$2.09 (+109.42%)
Price Chart
Overview
About TCRT
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
Market Cap
$16.0M
Volume
50.1K
Avg. Volume
160.8K
P/E Ratio
-4.283333
Dividend Yield
0.00%
Employees
39.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.91
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TCRT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$16.0M
Volume50.1K
P/E Ratio-4.28
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 1, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025